You are here: Home » PTI Stories » National » News
Business Standard

Aarti Drugs Q3 net dips 10 pc at Rs 20.89 cr

Press Trust of India  |  New Delhi 

Drug firm Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2018.

The company had posted a net profit of Rs 23.33 crore for the corresponding period of the previous fiscal, said in a filing to BSE.

Consolidated revenue from operations of the company however stood at Rs 380.11 crore for the quarter under consideration as against Rs 335.41 crore for October-December 2017.

Shares of closed at Rs 592.70 on BSE, up 1.50 per cent from the previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 11 2019. 16:05 IST